Specialty: Primary Care, Primary sub-specialty: Public Health
Conditions
Interventions
Patients will be randomly allocated to either the control or intervention group during the consultation through the on-line iQuit software.
Control group: Participants receive usual care alone. This
a breath test to measure CO and a discussion on stop smoking treatments that are available such as nicotine replacement therapies and Champix. Patients are also offered follow-up support and advice o
Sponsors
University of Cambridge
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Current smoker aged 16 - 75 2. Wants to quit and willing to attending for smoking cessation support at a GP practice 3. Owns a mobile phone and familiar with sending/receiving text messages 4. Able to read and understand English, and give informed written consent 5. Willing to set a quit-date within 14 days of starting the study 6. Not currently involved in another formal smoking cessation study
Exclusion criteria
Exclusion criteria: 1. Not meeting the inclusion criteria 2. Their GP feels that it would not be appropriate for them to participate (e.g. severe complex additional health problems)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-reported abstinence from smoking for 6 months endorsed by biochemical verification measured 6 months after the participant’s quit date. Abstinence from smoking will be measured 6 months after the participant’s quit date using a questionnaire (sent by the research team) followed by biochemical verification. All participants that have stated in the questionnaire they have not smoked for 6 months will be sent a kit to collect a saliva sample. The sample will be analysed for cotinine (a nicotine metabolite). If the sample is positive for cotinine then the sample will also be assayed for anabasine to differentiate whether the cotinine has come from tobacco, E-Cig or NRT. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Abstinence is measured using carbon monoxide (CO) testing at baseline and the routine follow-up 4-week appointment in the patient’s GP practice 2. Abstinence is measured through self-reporting using a questionnaire deigned for this study at 6 months (not biochemically validated) 3. Cost-effectiveness of the intervention is determined using a questionnaire at 6 months post quit date will determine NHS costs accumulated during the previous 6 months through questions on GP visits and medications prescribed, including NRTs | — |
Countries
England, United Kingdom
Contacts
Public ContactJoanna Mitchell
Outcome results
None listed